Current stock page

Stock Analysis

Sabra Health Care REIT, Inc. (SBRA) Stock Analysis

Sabra Health Care REIT, Inc. (SBRA) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

SBRA Stock Analysis Summary

Sabra Health Care REIT, Inc. (SBRA) currently has an AIQ Score of 46/100, indicating a neutral setup. Risk is the strongest factor at 68/100. Value is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Sep 11, 2026 · Market-close data

SBRA at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$20.52
AIQ Score46/100
Overall ViewNeutral
Technical Analysis ConsensusSell
Market Cap$5.28B
P/E Ratio79.32
Forward P/E
EPS-$0.10
Revenue TTM$235.87M
Dividend Yield0.02%
Beta0.64
Volume1.91M
52-week range$17.17-$22.77
RSI 1452.61
50-Day SMA$20.69
200-Day SMA$19.90
Analyst Price Target$22.00
Next EarningsNov 4, 2026
As of Sep 11, 2026 · Market close
Free research limit

Create a free account to keep researching stocks

You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.

SBRA

Overview
Sabra Health Care REIT, Inc.
Real Estate· REIT - Healthcare Facilities
AIQ Score
NeutralAIQ Edge 5/10
Low Priority
In Line With Peers
Score data as of Sep 11, 2026
Last price
$20.52
-$0.31 (-1.49%)
Latest market quote
Momentum50
Value31
Quality48
Risk Resilience68
Sentiment
View financial data

SBRA Stock Analysis Summary

Sabra Health Care REIT, Inc. (SBRA) currently has an AIQ Score of 46/100, indicating a neutral setup. Risk resilience is the strongest factor at 68/100. Value is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Sep 11, 2026 · Market-close data
AIQ Composite Posture: Mixed

In a neutral regime, SBRA has AIQ Score of 46/100 with Risk resilience base of 68/100 and fading Value at 31/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Risk resilience (68/100) leads while Value (31/100) lags. This cross-factor spread creates entry timing uncertainty.

Real Estate · -1.49% stock move · SBRA classified in REIT - Healthcare Facilities.

Current Evidence

NeutralSBRA is in a neutral AIQ regime; Risk resilience is the strongest visible factor at 68/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is SBRA Bullish or Bearish Right Now?

SBRA currently has a neutral overall setup. Risk Resilience is the strongest factor at 68/100, while Value is weakest at 31/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Risk Resilience is supportive at 68/100.
  • - Analyst target implies +7.21% upside from the latest quote.
Bear Case
  • - Value is the current constraint at 31/100.
  • - Technical consensus has more sell votes than buy votes (22 vs 15).

Current Consensus

SBRA's Technical Analysis Consensus is currently Sell, with 15 buy, 8 neutral, and 22 sell votes. SBRA's 14-day RSI is 52.61, which places the stock in a neutral momentum range. SBRA's beta is 0.64, indicating lower market sensitivity than the broad market.

Signal Confidence
Moderate agreement

What Changed in SBRA?

Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.

AIQ Score
46/100
Momentum
50/100
Quality
48/100
Risk
68/100

What Would Change the SBRA Outlook?

The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

SBRA Decision Framework

Public evidence layers, setup checks, and risk context for Sabra Health Care REIT, Inc..

Sabra Health Care REIT, Inc. (SBRA) Stock Analysis

Sabra Health Care REIT, Inc. has an AIQ Score of 46/100 in a Neutral regime. Risk is strongest at 68/100. Beta is 0.64, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextSBRA is in a Neutral AIQ regime with score 46/100.
Signal ConflictThe primary conflict is that risk leads at 68/100 while value lags at 31/100.
Factor EvidenceMomentum 50/100 · Value 31/100 · Quality 48/100 · Risk 68/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Risk is the strongest factor at 68/100.

TimingWait

Momentum is 50/100 and RSI (14) is 52.6.

Regime fitWait

SBRA is in a Neutral regime at 46/100.

Risk controlPass

Risk factor is 68/100 with beta 0.64 and annual volatility 24.17%.

ConflictWait

Current conflict: risk leads at 68/100 while value lags at 31/100.

AIQ Score
46/100
Price
$20.52
Beta
0.64
RSI (14)
52.6

SBRA Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

SBRA Fundamentals

SBRA valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$235.87M
Net income
-$25.2M
Free cash flow
$60.66M
View full SBRA fundamental analysis

SBRA Technical Analysis

SBRA technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Sell
RSI 14
52.61
Price vs SMA-50
-0.81%
View full SBRA technical analysis

SBRA Stock Catalysts

Track SBRA earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Nov 4, 2026
Analyst target
$22.00
News items
4
View SBRA earnings and stock catalysts

SBRA Dividend Analysis

SBRA dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
5.85%
Annual dividend
$1.20
Payout ratio
View SBRA dividend history and analysis

SBRA Financial Data

SBRA revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$235.87M
EPS
-$0.10
Periods
8
View SBRA financials

SBRA Risk Analysis

SBRA volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.64
Risk score
68/100
1Y volatility
24.17%
View SBRA risk analysis

SBRA Stock News

SBRA stock news, market tone, recent headlines, and catalyst context.

News items
4
Updated
Sep 11, 2026
Sentiment
Read SBRA stock news

SBRA vs REITs — Healthcare / Self-Storage / Hotels Peers

Current peer cohort: SBRA · SELF · SHO · VTR · WELL. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
SBRA
Current stock
0.2924.17%Current
SELF
Global Self Storage
-0.1518.38%SBRA vs SELF
SHO
Sunstone Hotel Investors
0.6623.44%SBRA vs SHO
VTR
Ventas
1.1122.31%SBRA vs VTR
WELL
Welltower
1.4422.69%SBRA vs WELL
Pairwise Compare links: SELF · SHO · VTR · WELLSBRA vs SELFSBRA vs SHOSBRA vs VTRSBRA vs WELLCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Sep 11, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a SBRA stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Sep 12, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
79.32
As of Sep 11, 2026
Revenue growth
6.36%
Gross margin
72.58%
Current debt / equity
0.96
Latest quarterly evidence

Latest period Jun 30, 2026.

Review fundamentals
Quarter revenue
$235.87M
Quarter net income
-$25.2M
Quarter free cash flow
$60.66M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Mixed
RSI 14
52.61
MACD
0.04

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
68/100
Beta
0.64
Annual volatility
24.17%
Max drawdown
-16.65%

SBRA Stock FAQ

What is SBRA stock price today?

Sabra Health Care REIT, Inc.'s current stock price is $20.52. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is SBRA bullish or bearish right now?

SBRA's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is SBRA's market cap?

SBRA's market cap is $5.28B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is SBRA's current P/E ratio?

SBRA's current P/E ratio is 79.32 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is SBRA's RSI?

SBRA's 14-day RSI is 52.61 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is SBRA above its 50-day and 200-day moving averages?

SBRA is -0.81% from its 50-day SMA and 3.13% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is SBRA's next earnings date?

SBRA's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does SBRA pay a dividend?

SBRA's dividend yield is 0.02% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.